Risk of cancer in pediatric-onset inflammatory bowel diseases: A nation-wide study from the epi-IIRN.
Ohad AtiaSasha HarelNatan LeddermanShira GreenfeldRevital KarivIris DotanRan BalicerBarbara SilvermanEran MatzZohar LeviMatti WatermanIris FriedJacob M RoweDan TurnerPublished in: Journal of Crohn's & colitis (2021)
PIBD confers an increased risk for malignancy compared with non-IBD children. However, the absolute risk is very low and no differences in risk with specific therapies were apparent in our data.